Daré Bioscience, Inc. (DARE) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 152.46K | 1.02M | 2.26K | -21.17K | 25.43K | -63.65K | 41.69K | 22.44K | 9.3K | 1.81M | 1M | 0 | 0 | 0 | 0 | 10M | 0 | 0 | 0 | 0 |
| Revenue Growth % | 499.58% | 1708.36% | -94.57% | -194.36% | 173.35% | -103.52% | -95.83% | - | - | - | - | -100% | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 796.97K | 295.8K | 0 | 0 | 2.3M | 14.22M | 25K | 0 | 3.36M | 21.56M | 25K | 25K | 25K | 4.72K | 25K | 25K | 25K | 25K | 25K | 25K |
| COGS % of Revenue | 522.76% | 28.9% | - | - | 9035.2% | -22345.96% | 59.97% | - | 36134.1% | 1192.72% | 2.5% | - | - | - | - | 0.25% | - | - | - | - |
| Gross Profit | -644.51K | 727.88K | 2.26K | -21.17K | -2.27M | -14.29M | 16.69K | 22.44K | -3.35M | -19.76M | 975K | -25K | -25K | -4.72K | -25K | 9.97M | -25K | -25K | -25K | -25K |
| Gross Margin % | -422.76% | 71.1% | 100% | 100% | -8935.2% | 22445.96% | 40.03% | 100% | -36034.1% | -1092.72% | 97.5% | - | - | - | - | 99.75% | - | - | - | - |
| Gross Profit Growth % | 71.63% | 105.09% | -86.45% | -194.36% | 32.22% | 27.68% | -98.29% | 189.75% | -13307.57% | -418708.33% | 4000% | -100.25% | 0% | 81.13% | 0% | 40000% | 0% | 0% | 0% | -20% |
| Operating Expenses | 2.35M | 2.2M | 3.67M | 3.81M | 2.31M | -8.9M | 4.7M | 7.38M | 2.67M | -14.58M | 9.37M | 8.96M | 8.36M | 16.2M | 7.11M | 9.59M | 8.38M | 9.52M | 12.64M | 9.14M |
| OpEx % of Revenue | 1544.31% | 214.83% | 162440.76% | -17979.54% | 9081.54% | 13980.21% | 11268.72% | 32899.12% | 28709.75% | -806.67% | 937.14% | - | - | - | - | 95.91% | - | - | - | - |
| Selling, General & Admin | 2.25M | 1.58M | 2.5M | 2.38M | 2.31M | 2M | 2.04M | 2.45M | 2.67M | 2.95M | 2.7M | 2.92M | 3.34M | 3.25M | 2.65M | 2.79M | 2.57M | 2.4M | 2.21M | 1.8M |
| SG&A % of Revenue | 1474.9% | 154.06% | 110488.15% | -11231.18% | 9081.54% | -3136.18% | 4896.18% | 10910.64% | 28709.75% | 163.44% | 269.68% | - | - | - | - | 27.93% | - | - | - | - |
| Research & Development | 152.46K | 622.04K | 1.18M | 1.43M | 2.3M | 3.31M | 2.66M | 4.93M | 3.35M | 3.8M | 6.67M | 6.04M | 5.02M | 12.98M | 4.46M | 6.8M | 5.81M | 7.12M | 10.43M | 7.34M |
| R&D % of Revenue | 100% | 60.77% | 51952.61% | -6748.36% | 9035.2% | -5202.35% | 6372.53% | 21988.47% | 36051.6% | 210.16% | 667.46% | - | - | - | - | 67.98% | - | - | - | - |
| Other Operating Expenses | -46.64K | 0 | 0 | 0 | -1000K | -1000K | 0 | 0 | -1000K | -1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3M | -1.47M | -3.67M | -3.83M | -4.58M | -5.39M | -4.68M | -7.36M | -6.02M | -5.17M | -8.4M | -8.99M | -8.38M | -16.21M | -7.14M | 384.32K | -8.4M | -9.54M | -12.67M | -9.16M |
| Operating Margin % | -1967.07% | -143.72% | -162340.76% | 18079.54% | -18016.75% | 8465.75% | -11228.68% | -32799.12% | -64743.85% | -286.05% | -839.64% | - | - | - | - | 3.84% | - | - | - | - |
| Operating Income Growth % | 34.54% | 72.69% | 21.56% | 47.99% | 23.93% | -4.19% | 44.25% | 18.13% | 28.16% | 68.09% | -17.62% | -2439.02% | 0.21% | -69.81% | 43.65% | 104.19% | -9.19% | -13.06% | -67.1% | -28.59% |
| EBITDA | -2.44M | -936.87K | -3.19M | -3.37M | -4.42M | -5.38M | -4.67M | -7.34M | -6.01M | -5.16M | -8.39M | -8.98M | -8.37M | -16.2M | -7.14M | 389.64K | -8.4M | -9.54M | -12.66M | -9.16M |
| EBITDA Margin % | -1603.26% | -91.52% | -141036.34% | 15906.5% | -17394.93% | 8455.75% | -11205.31% | -32730.32% | -64627.98% | -285.5% | -838.72% | - | - | - | - | 3.9% | - | - | - | - |
| EBITDA Growth % | 44.74% | 82.59% | 31.71% | 54.14% | 26.43% | -4.27% | 44.3% | 18.22% | 28.2% | 68.14% | -17.54% | -2404.62% | 0.26% | -69.89% | 43.65% | 104.26% | -9.21% | -13.07% | -67.29% | -28.71% |
| D&A (Non-Cash Add-back) | 554.64K | 534.39K | 481.91K | 460.07K | 158.11K | 6.37K | 9.74K | 15.44K | 10.78K | 9.98K | 9.26K | 9.62K | 9.51K | 4.72K | 3.03K | 5.32K | 5.23K | 7.05K | 6.34K | 6.61K |
| EBIT | -3M | -1.47M | -3.67M | -3.83M | -4.58M | -5.39M | -4.68M | -7.36M | -6.02M | -4.97M | -8.4M | -8.99M | -8.38M | -15.94M | -7.14M | 384.32K | -8.4M | -9.54M | -12.67M | -9.16M |
| Net Interest Income | -7.71K | 0 | 0 | -198.69K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 191.69K | 0 | 0 | 69.85K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 199.39K | 0 | 0 | 268.53K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -991 | 29.55K | 109.38K | -188.68K | 202.81K | -118.2K | -21.15K | 20.27M | -732.88K | 113.9K | 97.32K | 227.12K | 340.15K | 262.34K | 118.95K | 29.68K | 1.78K | 834 | 1.51K | 175 |
| Pretax Income | -3M | -1.44M | -3.56M | -4.02M | -4.38M | -5.51M | -4.7M | 12.91M | -6.76M | -5.06M | -8.3M | -8.76M | -8.04M | -15.94M | -7.02M | 414K | -8.4M | -9.54M | -12.67M | -9.16M |
| Pretax Margin % | -1967.72% | -140.84% | -157505.13% | 18970.73% | -17219.13% | 8651.47% | -11279.42% | 57539.25% | -72622.62% | -279.75% | -829.91% | - | - | - | - | 4.14% | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -3M | -1.44M | -3.56M | -4.02M | -4.38M | -5.51M | -4.7M | 12.91M | -6.76M | -5.06M | -8.3M | -8.76M | -8.04M | -15.94M | -7.02M | 414K | -8.4M | -9.54M | -12.67M | -9.16M |
| Net Margin % | -1967.72% | -140.84% | -157505.13% | 18970.73% | -17219.13% | 8651.47% | -11279.42% | 57539.25% | -72622.62% | -279.75% | -829.91% | - | - | - | - | 4.14% | - | - | - | - |
| Net Income Growth % | 31.48% | 73.82% | 24.24% | -131.11% | 35.19% | -8.87% | 43.34% | 247.34% | 16% | 68.28% | -18.22% | -2216.49% | 4.24% | -67.08% | 44.58% | 104.52% | -14.68% | -13.04% | -67.05% | -28.61% |
| Net Income (Continuing) | -3M | -1.44M | -3.56M | -4.02M | -4.38M | -5.51M | -4.7M | 12.91M | -6.76M | -5.06M | -8.3M | -8.76M | -8.04M | -15.94M | -7.02M | 414K | -8.4M | -9.54M | -12.67M | -9.16M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.21 | -0.10 | -0.28 | -0.45 | -0.50 | -0.65 | -0.55 | 1.52 | -0.81 | -0.69 | -1.09 | -1.22 | -1.13 | -2.34 | -0.98 | 0.06 | -0.10 | -0.13 | -2.97 | -0.18 |
| EPS Growth % | 58% | 84.71% | 49.09% | -129.61% | 38.27% | 5.8% | 49.54% | 224.59% | 28.32% | 70.51% | -11.22% | -2196.22% | -1030% | -1700% | 67% | 132.33% | 37.5% | 51.85% | -1137.5% | 33.33% |
| EPS (Basic) | -0.21 | -0.10 | -0.28 | -0.45 | -0.50 | -0.65 | -0.55 | 1.53 | -0.81 | -0.69 | -1.09 | -1.22 | -1.13 | -2.34 | -0.98 | 0.06 | -0.10 | -0.13 | -0.18 | -0.18 |
| Diluted Shares Outstanding | 14.52M | 14.5M | 12.76M | 8.87M | 8.76M | 8.5M | 8.53M | 8.48M | 8.38M | 7.3M | 7.59M | 7.2M | 7.13M | 6.8M | 7.07M | 7.11M | 7M | 4.34M | 4.27M | 4.2M |
| Basic Shares Outstanding | 14.52M | 14.5M | 12.76M | 8.87M | 8.76M | 8.5M | 8.53M | 8.41M | 8.38M | 7.3M | 7.59M | 7.2M | 7.13M | 6.8M | 7.07M | 7.11M | 7M | 4.34M | 4.27M | 4.2M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |